These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

497 related articles for article (PubMed ID: 19589728)

  • 1. Inflammation and colorectal cancer.
    Kraus S; Arber N
    Curr Opin Pharmacol; 2009 Aug; 9(4):405-10. PubMed ID: 19589728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory bowel disease: a model of chronic inflammation-induced cancer.
    Yang GY; Taboada S; Liao J
    Methods Mol Biol; 2009; 511():193-233. PubMed ID: 19347299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overview of molecular pathways in inflammatory bowel disease associated with colorectal cancer development.
    Azer SA
    Eur J Gastroenterol Hepatol; 2013 Mar; 25(3):271-81. PubMed ID: 23169309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation.
    Itzkowitz SH; Yio X
    Am J Physiol Gastrointest Liver Physiol; 2004 Jul; 287(1):G7-17. PubMed ID: 15194558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
    Brackmann S; Andersen SN; Aamodt G; Langmark F; Clausen OP; Aadland E; Fausa O; Rydning A; Vatn MH
    Scand J Gastroenterol; 2009; 44(1):46-55. PubMed ID: 18609187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammation in sporadic colorectal cancer.
    Moossavi S; Bishehsari F
    Arch Iran Med; 2012 Mar; 15(3):166-70. PubMed ID: 22369306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endoscopy/surveillance in inflammatory bowel disease.
    Ahmadi AA; Polyak S
    Surg Clin North Am; 2007 Jun; 87(3):743-62. PubMed ID: 17560423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The lymphatic system controls intestinal inflammation and inflammation-associated Colon Cancer through the chemokine decoy receptor D6.
    Vetrano S; Borroni EM; Sarukhan A; Savino B; Bonecchi R; Correale C; Arena V; Fantini M; Roncalli M; Malesci A; Mantovani A; Locati M; Danese S
    Gut; 2010 Feb; 59(2):197-206. PubMed ID: 19846409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-Aminosalicylic acid inhibits colitis-associated but not sporadic colorectal neoplasia in a novel conditional Apc mouse model.
    Koelink PJ; Robanus-Maandag EC; Devilee P; Hommes DW; Lamers CB; Verspaget HW
    Carcinogenesis; 2009 Jul; 30(7):1217-24. PubMed ID: 19420017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic ablation of Tnfalpha demonstrates no detectable suppressive effect on inflammation-related mouse colon tumorigenesis.
    Sakai H; Yamada Y; Shimizu M; Saito K; Moriwaki H; Hara A
    Chem Biol Interact; 2010 Mar; 184(3):423-30. PubMed ID: 20079348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential avenues for immunotherapy of colitis-associated neoplasia.
    Waldner MJ; Neurath MF
    Immunotherapy; 2012 Apr; 4(4):397-405. PubMed ID: 22512634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NF-kappaB in inflammatory bowel disease.
    Atreya I; Atreya R; Neurath MF
    J Intern Med; 2008 Jun; 263(6):591-6. PubMed ID: 18479258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Inflammation in the Development of Colorectal Cancer.
    Muthusami S; Ramachandran IK; Babu KN; Krishnamoorthy S; Guruswamy A; Queimado L; Chaudhuri G; Ramachandran I
    Endocr Metab Immune Disord Drug Targets; 2021; 21(1):77-90. PubMed ID: 32901590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Essential roles of IL-6 trans-signaling in colonic epithelial cells, induced by the IL-6/soluble-IL-6 receptor derived from lamina propria macrophages, on the development of colitis-associated premalignant cancer in a murine model.
    Matsumoto S; Hara T; Mitsuyama K; Yamamoto M; Tsuruta O; Sata M; Scheller J; Rose-John S; Kado S; Takada T
    J Immunol; 2010 Feb; 184(3):1543-51. PubMed ID: 20042582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic inflammatory bowel disease and cancer.
    Pohl C; Hombach A; Kruis W
    Hepatogastroenterology; 2000; 47(31):57-70. PubMed ID: 10690586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular pathways underlying IBD-associated colorectal neoplasia: therapeutic implications.
    Goel GA; Kandiel A; Achkar JP; Lashner B
    Am J Gastroenterol; 2011 Apr; 106(4):719-30. PubMed ID: 21386829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease.
    Sartor RB
    Gastroenterol Clin North Am; 1995 Sep; 24(3):475-507. PubMed ID: 8809232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proinflammatory cytokines and IL-10 in inflammatory bowel disease and colorectal cancer patients.
    Szkaradkiewicz A; Marciniak R; Chudzicka-Strugała I; Wasilewska A; Drews M; Majewski P; Karpiński T; Zwoździak B
    Arch Immunol Ther Exp (Warsz); 2009; 57(4):291-4. PubMed ID: 19578817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The role of cysteinyl leukotrienes in chronic inflammation and neoplasia of the intestine].
    Broom OJ; Nielsen OH
    Ugeskr Laeger; 2009 Jan; 171(4):243-6. PubMed ID: 19174041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis.
    Vera A; Gunson BK; Ussatoff V; Nightingale P; Candinas D; Radley S; Mayer A; Buckels JA; McMaster P; Neuberger J; Mirza DF
    Transplantation; 2003 Jun; 75(12):1983-8. PubMed ID: 12829898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.